LENZ Therapeutics, Inc. insider trading

By person

7 insiders · 11 transactions

0.3×

Evert Schimmelpennink holds only 0.3 times base salary in stock. $259.69K of shares against $690.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Evert Schimmelpennink last reported holding, valued at $3.36, the price Common Stock was last bought or sold at on the open market here, on 29 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ra Capital Management, L.p. entity

10% owner

—

$9.13M (3)

−$9.13M

57,559

0.1832%

$193.40K

−97.9%

Shawn Olsson

Chief Commercial Officer

—

$261.02K (2) scheduled

−$261.02K

4,733

0.0151%

$15.90K

—

Evert B. Schimmelpennink

President, CEO and Secretary

$251.41K (1)

—

+$251.41K

77,289

0.2460%

$259.69K

+71.8%

James W McCollum

Director

$239.28K (1)

—

+$239.28K

10,500

0.0334%

$35.28K

—

Daniel R. Chevallard

Chief Financial Officer

$114.29K (3)

—

+$114.29K

12,886

0.0410%

$43.30K

+304.2%

Jeffrey P. George

Director

$49.89K (1)

—

+$49.89K

5,592

0.0178%

$18.79K

—

Versant Venture Capital VI, L.P. entity

10% owner

—

1,814,726

5.78%

$6.10M

−51.0%

LENZ Therapeutics, Inc.

What the insiders did Net selling

By person